Our Research Methodology

To gain deep insights into the market’s potential, Infiniti’s team of market assessment experts
carried out primary research to gain more information about the launch strategy. To gauge more
information on the launch plan, the market assessment experts developed a robust market sizing
framework to help the client make informed decisions. Also, with our help the client was able to
design a launch strategy by keeping in mind the role of the key market segments.

Our Solution Helped the Client

 Identify potential segments and quantify the size of each market by specific geographies
 Identify robust data sources for estimating market potential
 Develop market assessment model for each of the segments
 Segregate segments in terms of countries, growth potential, and key variables
Benefits of Our Integrated Approach
In a very short period, the client was able to:

 Create customized market models for unique set of market definitions.

 Gain recommendations to build launch plan for new therapy
 Determine the market size and positioning across geographies
 Gauge the market demand for upcoming therapies across various regions
 India pharmaceuticals Industries

 The Indian pharmaceuticals market witnessed growth at a CAGR of 5.64 per cent, during FY11-16, with the market
increasing from US$ 20.95 billion in FY11 to US$ 27.57 billion in FY16. The industry’s revenues are estimated to have
grown by 7.4 per cent in FY17.
 Indian pharmaceutical market grew 5.5 per cent in CY2017 in terms of moving annual turnover. In March 2018, the
market grew at 9.5 per cent year-on-year with sales of Rs 10,029 crore (US$ 1.56 billion).
 By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and 6th largest market
globally in absolute size.
 Increase in the size of middle class households coupled with the improvement in medical infrastructure and increase in
the penetration of health insurance in the country will also influence in the growth of pharmaceuticals sector.

Export

 Indian pharma companies are capitalising on export opportunities in regulated and semi-regulated markets
 In FY17, India exported pharmaceutical products worth US$ 16.8 billion, with the number expected to reach US$ 40
billion by 2020. During April 2017–February 2018, India exported pharmaceutical products worth Rs. 767.17 billion (US$
11.90 billion).
 Indian drugs are exported to more than 200 countries in the world, with the US as the key market
 India is the world’s largest provider of generic medicines; the country’s generic drugs account for 20 per cent of global
generic drug exports (in terms of volumes)
 Around 40.6 per cent of India’s US$ 16.8 billion pharmaceutical exports in 2016-17 were to the American continent,
followed by a 19.7 per cent to Europe, 19.1 per cent to Africa and 18.8 per cent to Asian countries.